Skip to content

Comparison Of Intravenous Paracetamol, Intravenous Diclofenac And Their Combination For Perioperative Analgesia In Patients Undergoing Laparoscopic Cholecystectomy

Comparison Of Intravenous Paracetamol, Intravenous Diclofenac And Their Combination For Perioperative Analgesia In Patients Undergoing Laparoscopic Cholecystectomy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017097
Enrollment
90
Registered
2019-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere

Interventions

Intervention1: dr shivam: post graduate resident 1st year department of anaesthesia vardhman mahavir medical college and safdarjung hospital new delhi 110029 Intervention2: POSTOPERATIVE PERIOD IV In

Sponsors

Department Of Anaesthesia Vardhman Mahavir Medical college And Safdarjung Hospital New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients scheduled to undergo elective laparoscopic cholecystectomy under general anaesthesia 2. Age 18-65 years,either gender. 3. Patients fulfilling American Society of Anesthesiologists physical status I or II . 4. Weight 45-75 kgs. 5. BMI less than or equal to 35

Exclusion criteria

Exclusion criteria: 1. Patient with known allergy to PCM/diclofenac. 2. Bronchial asthma , COPD. 3. Renal dysfunction, Liver dysfunction, Bleeding diathesis. 4. Psychological disorder. 5. Morbid obesity. 6. Laparoscopic cholecystectomy converted to open cholecystectomy intraoperatively.

Design outcomes

Primary

MeasureTime frame
To assess:- Requirement of IV fentanyl intraoperatively VAS in the immediate postoperative period (15 minutes). Timepoint: To assess:- Requirement of IV fentanyl intraoperatively VAS in the immediate postoperative period (15 minutes). trail study period 18 months

Secondary

MeasureTime frame
Duration of effective analgesia. [ From the end of surgery till the time patient requires the 1st postoperative analgesic ] Requirement of analgesics in the postoperative period in 24 hoursTimepoint: Duration of effective analgesia. [ From the end of surgery till the time patient requires the 1st postoperative analgesic ] Requirement of analgesics in the postoperative period in 24 hours trial study period 18 months

Countries

India

Contacts

Public ContactDr Vandana Talwar

vardhman mahavir medical college and safdarjung hospital new delhi

drvandanatalwar@gmail.com9811352251

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026